ESG

Alvotech and Teva's settlement with Regeneron for an Eylea biosimilar paves the way for a 2026 launch, promising increased competition and lower costs.

A new settlement positions a cost-effective alternative to the blockbuster eye drug Eylea for a 2026 U.S. launch, signaling intense market disruption.

A new joint venture aims to redefine Tallinn's skyline with a potential 60-storey high-rise, part of a major expansion in the Manufaktuuri quarter.

In a major move for the AI infrastructure race, TeraWulf and Fluidstack secure massive project financing for a 168 MW Texas facility, backed by Google.

Nuveen is combining three tax-free income funds. For investors, this means lower fees and stable payouts, but also new state tax implications.

Titan Mining's new funding aims to end a 70-year U.S. graphite production gap, a critical move for the nation's EV and energy independence goals.

As Applied Digital preps its Q2 results, investors watch to see if its multi-billion dollar contracts can quell market volatility and affirm its AI future.

A look inside the revolutionary mass timber, net-zero building that's setting a new global standard for sustainable construction and education.

A new oral drug, cadisegliatin, enters a major clinical trial in the UAE, aiming to help Type 2 diabetes patients struggling with insulin therapy.

Avocado giant Mission Produce sets a new course, naming a successor to its founder CEO and refreshing its board to navigate future global market demands.

Altus Power acquires over 100 solar and storage sites from Greenbacker, boosting its capacity to 1.3 GW and signaling a new phase of consolidation.

Medical supply giant Medline closes 2025's largest IPO, raising billions to slash debt and fuel growth, cementing its dominance in the healthcare sector.

A Minnesota startup has secured major funding to advance its bioelectronic device aimed at the brain's waste clearance system for treating CNS disorders.

Eight top US students will join a fully funded internship in Copenhagen to learn from Denmark's world-class sustainability, forging a new path for green careers.

A simple, low-cost heart pill may hold the key to treating Alzheimer's and kidney disease. CardioPharma is now funding research to unlock its potential.

A new report projects a staggering $47T cost from chronic illness by 2039. Experts say prevention and innovation could save trillions and 13.5M lives.

Syra Health appoints Gregory R. Alexander as CEO, banking on his military discipline and record of scaling healthcare firms to drive its next growth phase.

Get ready for a car that knows you. Cinemo's agentic AI promises hyper-personalized rides, blurring the lines between your vehicle and your digital life.

RELEX Solutions' strategic acquisition of Ida aims to revolutionize fresh food management, promising less waste, higher sales, and a smarter supply chain.

A major partnership brings high-tech, locally grown organic herbs to Mid-Atlantic shelves, aiming to slash food miles and redefine retail freshness.